Agency commissioners voted unanimously on Tuesday to publish the report, which makes a similar attack on the drug middlemen as the agency’s first report, but draws on more data.

Mintz’s Health Law and Antitrust teams actively monitor federal and state regulatory and legislative developments in the PBM ...

The largest pharmacy-benefit managers hiked ... vice president of the Pharmaceutical Care Management Association, a trade association representing PBMs. The FTC analyzed data submitted by the ...

were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price markups on specialty generic drugs, according to a new ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.